KTTA — Pasithea Therapeutics Share News
0.000.00%
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement
NASDAQ RESUMED AT 09:37 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
NASDAQ RESUMED AT 10:57 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:52 AM
NASDAQ RESUMED AT 10:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:44 AM
NASDAQ RESUMED AT 10:23 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:18 AM
NASDAQ RESUMED AT 10:16 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM
NASDAQ RESUMED AT 09:49 AM